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Breast cancer (BC) is the most frequently diagnosed
cancer in women around the world, and an esti-
mated15-20% of BC cases present with a family history
of disease. Genetic variants in known susceptibility
genes explain a relatively small proportion of the herita-
ble risk for BC. Genetic variants have been broadly clas-
sified into three categories with different levels of risk
and prevalence: rare mutations in high-risk genes (e.g.
BRCA1, BRCA2); rare mutations in intermediate-risk
genes (e.g. CHEK2); and common very modest-risk
genetic variants (identified throughout the genome).
These categories currently account for 20%, 5% and
~15% of the familial risk, respectively, leaving about 60%
of the familial BC risk to be determined.
We have conducted whole-exome capture followed by
massive parallel sequencing (XC-MPS)-based analysis on
greater than third degree affected relatives from highly
selected multiple-case BC families (at least four cases of
invasive breast cancer diagnosed before 50 years) which
had previously been screened and found not to carry
identifiable BRCA1 or BRCA2 mutations.
In this presentation, we focus on two candidate BC
susceptibility genes identified by this analysis, each play-
ing a key-role in DNA repair. In both cases, one indivi-
dual from the pair of cousins was found to carry a
predicted protein damaging genetic variant at a consen-
sus splice site. The variants were confirmed and
extended analysis within the respective pedigrees
performed by Sanger sequencing, subject to DNA sam-
ple availability. Further characterization of these variants
is being pursued by much larger scale case-control gen-
otyping using the TaqMan platform.
Our work further illustrates the complexities of
human genetic variation and the technical and analytical
challenges of identifying variation that is associated with
inherited predisposition to complex diseases such as
breast cancer.
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